Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
93.53
+2.96 (3.27%)
At close: Aug 21, 2026, 4:00 PM EDT
93.68
+0.15 (0.16%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.58 billion as of August 21, 2026. Its market cap has increased by 121.18% in one year.
Market Cap
4.58B
Enterprise Value
4.58B
1-Year Change
121.18%
Ranking
Category
Stock Price
$93.53
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.58B, an increase of 3,317.92%. That is a compound annual growth rate of 48.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.58B | -0.83% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 5.08B |
| Dyne Therapeutics | 4.87B |
| Parabilis Medicines | 4.86B |
| Edgewise Therapeutics | 4.80B |
| Enliven Therapeutics | 4.38B |
| Veradermics | 4.30B |
| Relay Therapeutics | 4.26B |
| Legend Biotech | 4.23B |